Worldwide collaboration for the Galileo Tissue Microarray – 100% traceable TMA workflow

Worldwide collaboration for the Galileo Tissue Microarray – 100% traceable TMA workflow
Today ISENET and Visiopharm announce a non-exclusive world-wide distribution agreement to provide Visiopharm image analysis with the Galileo TMA instrument, along with the Visiopharm Tissuearray™ imaging module, a part of ONCOTOPIX®, for tissue-ba...
Read more

Debunked: Digital Pathology Misconceptions

Debunked: Digital Pathology Misconceptions
Below is an article I recently wrote for ADVANCE for Administrators of the Laboratory. There is also some other articles under “related content” that are good reads on the topic. Debunked: Digital Pathology Misconceptions There is hesitation i...
Read more

Part 2: Digital Pathology is Not an LDT! Now What?

Part 2: Digital Pathology is Not an LDT! Now What?
The Digital Pathology Association’s FDA Task Force prepared four questions for the Regulatory Panel session held at the Pathology Visions conference last week. The third, two part question was: Does WSI fit within the paradigm of a La...
Read more